tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Rhythm Pharmaceuticals Inc (RYTM)
NASDAQ:RYTM
US Market
RYTM
Rhythm Pharmaceuticals
RESEARCH TOOLSreports

Rhythm Pharmaceuticals (RYTM) Stock News & Sentiment

Compare
600 Followers
Rhythm Wins FDA Nod for Hypothalamic Obesity Therapy
Premium
Company Announcements
Rhythm Wins FDA Nod for Hypothalamic Obesity Therapy
3d ago
8K
RYTM
Palatin’s Case Strengthens as Rhythm’s FDA Approval Validates Hypothalamic Obesity Market (PTN)
Premium
TipRanks Newswire
Palatin’s Case Strengthens as Rhythm’s FDA Approval Validates Hypothalamic Obesity Market (PTN)
3d ago
PTN
RYTM
Rhythm Pharmaceuticals: EMANATE Setback but Validated MC4R Mechanism and Pipeline Optionality Support Lowered $100 Buy Rating
Premium
Ratings
Rhythm Pharmaceuticals: EMANATE Setback but Validated MC4R Mechanism and Pipeline Optionality Support Lowered $100 Buy Rating
5d ago
RYTM
Maintaining a Buy: Setmelanotide’s PDUFA Catalyst and Subgroup Signals Offset EMANATE Miss
Premium
Ratings
Maintaining a Buy: Setmelanotide’s PDUFA Catalyst and Subgroup Signals Offset EMANATE Miss
6d ago
RYTM
Maintained Buy on Rhythm Pharmaceuticals: EMANATE Setback Offset by Core Obesity Franchise and Pipeline Upside
Premium
Ratings
Maintained Buy on Rhythm Pharmaceuticals: EMANATE Setback Offset by Core Obesity Franchise and Pipeline Upside
6d ago
RYTM
Rhythm Pharmaceuticals Reports Mixed Phase 3 EMANATE Results
Premium
Company Announcements
Rhythm Pharmaceuticals Reports Mixed Phase 3 EMANATE Results
6d ago
8K
RYTM
Rhythm Pharmaceuticals Balances Strong Growth With Rising Costs
Premium
Company Announcements
Rhythm Pharmaceuticals Balances Strong Growth With Rising Costs
16d ago
RYTM
More RYTM News >

RYTM News on the Web

RA CAPITAL MANAGEMENT, L.P. Reduces Stake in Solid Biosciences Inc
GuruFocus News
Neutral
RA CAPITAL MANAGEMENT, L.P. Increases Stake in Acumen Pharmaceuticals Inc
GuruFocus News
Neutral
RA CAPITAL MANAGEMENT, L.P. Increases Stake in Vor Biopharma Inc
GuruFocus News
Neutral
PERCEPTIVE ADVISORS LLC Acquires Significant Stake in Edesa Biotech Inc
GuruFocus News
Neutral
Rhythm Pharmaceuticals selects Pantherx Rare as pharmacy for Imcivree
TipRanks News
Bullish
Palatin's Case Strengthens as Rhythm's FDA Approval Validates Hypothalamic Obesity Market (PTN)
GuruFocus News
Neutral
Rhythm Wins FDA Nod for Hypothalamic Obesity Therapy
TipRanks News
Bullish
Rhythm Pharmaceuticals price target raised to $149 from $139 at BofA
TipRanks News
Bullish

News Score - Last 7 Days

Neutral
RYTM
Sector Average
Media Buzz
This Week37 articles
Weekly Average19.75 articles
News Sentiment
This Week68%
Sector Average67%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is RYTM’s Media Buzz Sentiment?
37 articles about RYTM were published this week. In an average week, 19.75 articles are published.
    What is RYTM’s weekly average amount of articles?
    In an average week, 19.75 articles about RYTM are published.
      What is RYTM’s News Sentiment?
      68% of articles about RYTM were positive this week, compared to its sector average of 67%.
        Healthcare Stocks that are Trending in the News
        KHTRFKnight Therapeutics
        KMTSKestra Medical Technologies Ltd.
        OVIDOvid Therapeutics
        PYPDPolyPid
        BCYCBicycle Therapeutics
        Showing the stocks with the most bullish news sentiment over the past week